Sanofi India Limited
Sanofi India Limited, a subsidiary of the global healthcare leader Sanofi, is headquartered in Mumbai, India. Established in 1956, the company has made significant strides in the pharmaceutical industry, focusing on areas such as diabetes, cardiovascular health, and vaccines. With a strong presence across major operational regions in India, Sanofi India is committed to improving patient outcomes through innovative healthcare solutions. The company offers a diverse portfolio of core products, including insulin therapies and specialty medicines, which are distinguished by their quality and efficacy. Sanofi India has achieved notable market recognition, consistently ranking among the top pharmaceutical companies in the country. With a dedication to research and development, Sanofi India continues to advance healthcare, making a meaningful impact on the lives of patients across the nation.
DitchCarbon Score
How does Sanofi India Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanofi India Limited's score of 58 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sanofi India Limited's reported carbon emissions
In 2022, Sanofi India Limited reported total carbon emissions of approximately 4,836,300 kg CO2e for Scope 1 and about 9,136,160 kg CO2e for Scope 2. This reflects a slight increase in Scope 1 emissions from 484,010 kg CO2e in 2021, while Scope 2 emissions decreased from approximately 10,368,230 kg CO2e in the previous year. Sanofi India Limited operates as a current subsidiary of Sanofi, which cascades its climate commitments and emissions data. However, there are no specific reduction targets or climate pledges disclosed at the subsidiary level. The company has not reported any Scope 3 emissions data, indicating a focus primarily on direct and indirect emissions from energy consumption. Sanofi India Limited's emissions data and climate initiatives are part of a broader commitment to sustainability, inherited from its parent company, Sanofi, which is actively engaged in various climate initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP).
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 484,010 | 000,000 |
| Scope 2 | 10,368,230 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanofi India Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
